Publications by authors named "Jeff Maca"

Claim this Profile
E
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
Patricia Pozo-Rosich, David Dolezil, Koen Paemeleire, Adam Stepien, Philipp Stude, Jeff Maca

JAMA Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics.
Robin A Huff, Jeff D Maca, Mala Puri, Earl W Seltzer

Pediatr Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Challenges and Opportunities of "Less Well-Understood" Adaptive Designs.
Weili He, Paul Gallo, Eva Miller, Yannis Jemiai, Jeff Maca

Ther Innov Regul Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive Designs.
Eva Miller, Paul Gallo, Weili He, Lisa A Kammerman, Kenneth Koury, Jeff Maca

Ther Innov Regul Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group.
Alan Phillips, Chrissie Fletcher, Gary Atkinson, Eddie Channon, Abdel Douiri, Jeff Maca

Pharm Stat· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Clinical Trials: Overview of Phase III Designs and Challenges.
Jeff Maca, Vladimir Dragalin, Paul Gallo

Ther Innov Regul Sci· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development.
Judith Quinlan, Brenda Gaydos, Jeff Maca, Michael Krams

Clin Trials· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.
Maurizio Salvadori, Herwig Holzer, Angelo de Mattos, Hans Sollinger, Wolfgang Arns, Jeff Maca

Am J Transplant· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis